On the 4th of May 2022, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. Major items approved by the Annual General Meeting include: The annual financial report regarding 2021 was approved by the AGM. Disposition of financial results…
ContextVision’s CEO Ola Lindblad will present the highlights for the first quarter 2022, followed by a Q&A session. Hosted by SpareBank 1 Markets Time: 22. April 2022 at 12.00 CET Register below:
The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8). “It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical…
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding…
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: finance@contextvision.se For inquiries, please contact…
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK…
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business.…
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…